Search filters

List of works by Riccardo Danielli

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

scientific article published on 21 February 2018

Armed antibodies for cancer treatment: a promising tool in a changing era.

scientific article

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

scientific article

Clinical studies with anti-CTLA-4 antibodies in non-melanoma indications.

scientific article published on October 2010

Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study.

scientific article

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

scientific article published on 25 September 2013

Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.

scientific article published in May 2010

Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies

scientific article

Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.

scientific article

False Leser-Trélat sign

scientific article published on 01 August 2009

ICOS Expression as Immunologic Marker in Immune Activating Monoclonal Antibodies.

scientific article published on January 2016

Immunologic checkpoints blockade in renal cell, prostate, and urothelial malignancies.

scientific article published on 12 February 2015

Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide.

scientific article

Immunotherapy targeting immune check-point(s) in brain metastases

scientific article

Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study

scientific article published on 14 May 2015

Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.

scientific article

Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy).

scientific article published on 18 December 2010

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

scientific article

Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptides

scientific article published on 2 October 2012

Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.

scientific article published on 17 April 2013

Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab

scientific article published on 12 April 2017

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients.

scientific article published on 8 May 2017

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

scientific article published on 23 December 2014

Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.

scientific article published on October 2012

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

scientific article published on 11 September 2013

Paulina is supported by:

About Paulina

Help